The final oxidation step in a metabolic pathway, called the retinoid (visual) cycle, is catalyzed by 11-
cis-retinol dehydrogenases (RDHs).
1 2 This cycle of reactions is responsible for the production of 11-
cis-retinal, a chromophore of visual pigments.
3 4 Disruption of the main RDH enzyme in humans, RDH5, causes
Fundus albipunctatus.
5 Initially, it was thought that
F. albipunctatus was an autosomal recessive form of congenital stationary night blindness characterized by the appearance of numerous small white dots in the retinal pigment epithelium (RPE) and by delays in dark adaptation.
6 However, more recently it was demonstrated that progressive cone dystrophy developed in some patients with
F. albipunctatus.
7 8 9 In mice, RDH5 is responsible for most 11-
cis-RDH activity, but a second RDH—RDH11—plays a complementary role.
10 The phenotype of RDH5 knockout in mice is milder than it is in humans; thus, human conditions are mimicked more closely in
Rdh5 –/– Rdh11 –/– mice, and these mice were chosen for our study.
11 These mouse models, with disrupted genes encoding 11-
cis-RDH, showed delayed dark adaptation with slow 11-
cis-retinal regeneration but lacked the retinal structural abnormalities that are typically observed in human diseases with mutation in the
RDH5 gene.
10 12 13 Interestingly, an accumulation of
cis-retinyl esters, mainly 13-
cis-retinyl ester, was detected in mice with disrupted 11-
cis-RDH genes,
12 13 and this accumulation can be related to the pathology of
F. albipunctatus.
11